THIS JUST IN

There’s a lot of buzz about Ozempic and newly approved prescription weight-loss medications on the market. While these GLP-1 agonists were originally created as effective ways to manage type 2 diabetes, the weight loss side effect (caused by early fullness and less hunger, leading to consuming less food), has consumers requesting these meds in droves. Several medications in this class have now been FDA-approved strictly for weight-loss for those with comorbidities of obesity. We’re seeing exciting results, but these medications are not without their issues, including a supply shortage causing diabetics to be denied access….